Magnetar Capital

Magnetar Capital, LLC is a privately owned alternative asset management firm founded in April 2005 and headquartered in Evanston, Illinois. The firm specializes in investing across various asset classes, including public equity, fixed income, corporate credit, real estate, and energy-related assets. Magnetar Capital employs a blend of fundamental and quantitative analysis to identify unique investment opportunities and aims to deliver consistent, long-term, risk-adjusted returns. The firm's investment strategies encompass global event-driven, fixed income, energy, and quantitative approaches. In addition to its headquarters, Magnetar Capital has satellite offices in major cities including New York, Philadelphia, London, and Beijing, enhancing its capacity to source and manage investments around the world.

Ernie Rogers

COO and CFO

Eric Scheyer

Head of Energy and Infrastructure, Member of Management and Chair of Energy Investment Committee

Neil Tiwari

Founding Member

Michael Dean

Managing Director

33 past transactions

Apptronik

Series A in 2025
Apptronik specializes in developing humanoid robots designed for various real-world applications. Their robots are capable of handling tasks typically performed by humans, such as case picking, down stacking, trailer unloading, palletizing, sortation, and heavy lifting. This enables industries to address labor shortages, improve job satisfaction, and enhance efficiency.

Endera

Venture Round in 2025
Endera is a technology company focused on providing comprehensive solutions for commercial electric vehicle (EV) needs. It designs, sells, and services premium all-electric commercial vehicles, along with charging stations and energy products. By integrating advanced software systems with its product offerings, Endera aims to deliver innovative and efficient EV solutions that cater to the demands of modern transportation. The company specializes in smart electric fleet vehicles and utilizes artificial intelligence to enhance dispatch systems and mobility software services. Endera's goal is to ensure that its vehicles are dependable, technologically advanced, cost-effective, and energy-efficient, positioning itself as a leader in the transition to sustainable commercial transportation.

CoreWeave

Secondary Market in 2024
CoreWeave develops a cloud infrastructure platform specializing in GPU-powered computing for blockchain initiatives. Its platform offers efficient scaling, tailored compute resources, and automated management tools to support advanced AI infrastructure.

CoreWeave

Debt Financing in 2024
CoreWeave develops a cloud infrastructure platform specializing in GPU-powered computing for blockchain initiatives. Its platform offers efficient scaling, tailored compute resources, and automated management tools to support advanced AI infrastructure.

CoreWeave

Series C in 2024
CoreWeave develops a cloud infrastructure platform specializing in GPU-powered computing for blockchain initiatives. Its platform offers efficient scaling, tailored compute resources, and automated management tools to support advanced AI infrastructure.

Comtech Telecommunications

Post in 2024
Comtech designs, develops, produces, and markets advanced communication products, systems, and services. It operates in two segments: Satellite and Space Communications, which is a market leader in troposcatter technologies serving defense contractors globally; and Terrestrial and Wireless Networks, focusing on next-generation 911 infrastructure.

CoreWeave

Debt Financing in 2023
CoreWeave develops a cloud infrastructure platform specializing in GPU-powered computing for blockchain initiatives. Its platform offers efficient scaling, tailored compute resources, and automated management tools to support advanced AI infrastructure.

CoreWeave

Series B in 2023
CoreWeave develops a cloud infrastructure platform specializing in GPU-powered computing for blockchain initiatives. Its platform offers efficient scaling, tailored compute resources, and automated management tools to support advanced AI infrastructure.

CoreWeave

Series B in 2023
CoreWeave develops a cloud infrastructure platform specializing in GPU-powered computing for blockchain initiatives. Its platform offers efficient scaling, tailored compute resources, and automated management tools to support advanced AI infrastructure.

Arcadia

Venture Round in 2022
Arcadia, Inc. is a technology company based in Washington, D.C., founded in 2014, that focuses on providing access to clean energy solutions. Through its platform, Arc, the company connects subscribers to renewable energy sources such as wind farms and community solar projects. By enabling users to manage their accounts, track energy usage, and participate in clean energy initiatives, Arcadia aims to democratize access to renewable energy and combat the fossil fuel monopoly. The platform aggregates energy data from over 125 utilities, representing more than 80% of U.S. electric utility accounts, thus facilitating a significant shift toward sustainable energy practices. Additionally, Arcadia's community solar program addresses energy injustice while promoting economic growth, contributing over five Terawatt-hours of energy demand from residential and commercial users.

CoreWeave

Debt Financing in 2022
CoreWeave develops a cloud infrastructure platform specializing in GPU-powered computing for blockchain initiatives. Its platform offers efficient scaling, tailored compute resources, and automated management tools to support advanced AI infrastructure.

Stacked Farm

Venture Round in 2022
Stacked Farm specializes in automated indoor vertical farming, producing fresh, pesticide-free produce year-round. Their technology ensures high yields and minimal environmental impact.

Activ Surgical

Series B in 2022
Activ Surgical Inc. is a digital surgery company based in Boston, Massachusetts, dedicated to enhancing surgical procedures through advanced technology. Established in 2014 and originally known as Omniboros Inc., the company specializes in developing a robotic surgery platform that integrates computer vision, artificial intelligence, and robotics. Its flagship product, the Smart Tissue Autonomous Robot (STAR), is designed to improve surgical efficiency, accuracy, and patient outcomes while reducing the risk of unintended complications. Activ Surgical's innovative, patent-protected surgical software facilitates augmented reality-based and AI-driven operations, thereby enhancing surgeons' intra-operative decision-making and fostering safer surgical practices.

Enable Injections

Series C in 2022
Enable Injections designs and manufactures wearable devices that deliver injectable drugs directly into the subcutaneous tissue. The system accepts standard vials, syringes, or cartridges, automatically reconstitutes lyophilized solutions, warms the drug, and injects high‑viscosity or high‑volume payloads up to 20 ml. Users place the device on the skin, press a central button, and monitor delivery progress through a viewing window before disposing of the single‑use injector. The company also offers transfer systems for partial or multi‑vial filling and a Bluetooth‑enabled version that can connect to smartphones. Founded in 2010, the company is headquartered in Cincinnati, Ohio, and targets a growing market for self‑administration of biologics and other therapeutics.

Virb

Venture Round in 2021
Virb is a company focused on addressing the significant supply-demand gap in the clinical trial industry, which is estimated to reach over 15% annually. By leveraging its innovative ed-tech, SaaS-like software platform, Virb aims to create a skilled entry-level workforce for clinical trials. The platform sources, trains, and deploys new talent, enabling the healthcare sector to meet the increasing demand for qualified professionals in clinical research. Founded by Garrett, a former Chief Human Resources Officer at IQVIA, Virb is led by a team of experienced HR and talent executives, positioning it as a vital resource in the effort to facilitate pharmaceutical growth and bring novel drugs to market efficiently.

CoreWeave

Private Equity Round in 2021
CoreWeave develops a cloud infrastructure platform specializing in GPU-powered computing for blockchain initiatives. Its platform offers efficient scaling, tailored compute resources, and automated management tools to support advanced AI infrastructure.

Comtech Telecommunications

Post in 2021
Comtech designs, develops, produces, and markets advanced communication products, systems, and services. It operates in two segments: Satellite and Space Communications, which is a market leader in troposcatter technologies serving defense contractors globally; and Terrestrial and Wireless Networks, focusing on next-generation 911 infrastructure.

Activ Surgical

Series B in 2021
Activ Surgical Inc. is a digital surgery company based in Boston, Massachusetts, dedicated to enhancing surgical procedures through advanced technology. Established in 2014 and originally known as Omniboros Inc., the company specializes in developing a robotic surgery platform that integrates computer vision, artificial intelligence, and robotics. Its flagship product, the Smart Tissue Autonomous Robot (STAR), is designed to improve surgical efficiency, accuracy, and patient outcomes while reducing the risk of unintended complications. Activ Surgical's innovative, patent-protected surgical software facilitates augmented reality-based and AI-driven operations, thereby enhancing surgeons' intra-operative decision-making and fostering safer surgical practices.

Benson Hill

Venture Round in 2021
Benson Hill is an agricultural technology company that specializes in crop improvement and soy protein innovation. The company focuses on unlocking the natural genetic diversity of plants to develop healthier, more sustainable food and ingredients. Its proprietary CropOS platform leverages machine learning and big data alongside traditional breeding techniques to streamline and expedite the product development process. Benson Hill operates a Crop Accelerator designed for rapid prototyping and is actively developing a seed portfolio that includes protein ingredients, aquaculture, specialty animal feed, and vegetable oils. The company generates revenue from both proprietary and non-proprietary product categories, with proprietary revenue stemming from the sale of its unique bean varieties.

Vedanta Biosciences

Series D in 2021
Vedanta Biosciences is a clinical-stage microbiome company focused on developing therapies for immune-mediated and infectious diseases using live bacteria derived from the human microbiome. The company designs orally delivered defined bacterial consortia, leveraging libraries of microbiome-derived strains, proprietary datasets from human interventional studies, and tools for selecting potent strains. Its platform encompasses consortium design and CGMP manufacturing of bacterially defined products, enabling physicians to access live bacteria drugs for autoimmune and inflammatory conditions. Headquartered in Cambridge, Massachusetts, Vedanta Biosciences aims to create a new category of oral therapies arising from defined bacterial communities grown from clonal cell banks.

Evolv Technology

Post in 2021
Evolv Technology specializes in touchless security screening systems, ensuring safety without compromising visitor experience. Headquartered in Waltham, Massachusetts, the company offers advanced solutions integrating real-time video surveillance with low false alarms, firearm and explosive detection, facial recognition, and security analytics.

OncoResponse

Series C in 2021
OncoResponse is an immuno‑oncology biotechnology company that uses a proprietary human antibody platform to discover novel targets and develop fully human monoclonal antibodies for cancer treatment. By interrogating the adaptive immune system of patients who respond exceptionally well to checkpoint inhibition, the company identifies genuine human antibodies against high‑value targets linked with immunosuppressive myeloid biology. Its pipeline aims to alleviate tumor‑microenvironment immunosuppression and enhance immune activation, converting cold tumors into hot ones and providing new therapeutic options for patients.

Judo Bank

Series D in 2020
Judo Bank is an Australian financial institution dedicated to serving small and medium-sized enterprises (SMEs). Recognizing the significance of SMEs in the Australian economy, Judo offers a range of lending products, including business loans, equipment finance, lines of credit, and home loans, specifically designed to meet the unique needs of these businesses. The bank prioritizes relationship-based banking, enabling customers to engage directly with empowered decision-makers who evaluate applications based on individual merits rather than rigid processes. This personalized approach fosters strong relationships, allowing Judo to tailor financial solutions that align with each client's specific circumstances. With a focus on integrity and practical banking, Judo aims to provide the support that many SMEs have traditionally lacked, leveraging both experience in high-level banking and the agility of a more specialized institution.

Imvax

Series C in 2020
Imvax, Inc. is a clinical-stage biotechnology company based in Philadelphia, Pennsylvania, focused on developing innovative, patient-specific vaccines and immunotherapy strategies for the treatment of malignant gliomas and other cancers with significant unmet medical needs. Incorporated in 2015, Imvax's primary product, IGV-001, is an autologous tumor cell vaccine designed to harness the patient's immune system to generate a robust response against tumor cells. The company employs advanced methodologies, including patient cell harvest and treatment, immunogenic cell death, and activation of both the innate and adaptive immune systems, to enhance therapeutic outcomes. Through its novel approach, Imvax aims to provide effective treatments for patients facing challenging cancer diagnoses.

Imvax

Series B in 2019
Imvax, Inc. is a clinical-stage biotechnology company based in Philadelphia, Pennsylvania, focused on developing innovative, patient-specific vaccines and immunotherapy strategies for the treatment of malignant gliomas and other cancers with significant unmet medical needs. Incorporated in 2015, Imvax's primary product, IGV-001, is an autologous tumor cell vaccine designed to harness the patient's immune system to generate a robust response against tumor cells. The company employs advanced methodologies, including patient cell harvest and treatment, immunogenic cell death, and activation of both the innate and adaptive immune systems, to enhance therapeutic outcomes. Through its novel approach, Imvax aims to provide effective treatments for patients facing challenging cancer diagnoses.

Exo

Series B in 2019
Exo is a medical device startup specializing in handheld ultrasound technology. It combines advanced materials, sensors, signal processing, and computation with semiconductor manufacturing economies to deliver affordable, high-quality imaging. This empowers healthcare professionals to make critical real-time decisions, enhancing patient outcomes.

Lucid Energy Group

Private Equity Round in 2017
Founded in 2011 with headquarters in Dallas, Lucid Energy Group specializes in midstream services for producers in the Permian Basin. The company offers gathering, treating, processing, compression, and transportation services, focusing on high-growth areas like the Wolfcamp and Clines shales. Lucid's commitment to unique solutions and clear communication sets it apart, earning trust from its customers.

Fountainhead Commercial Capital

Series A in 2016
Fountainhead is a provider of direct commercial lending services focused on assisting small and midsized business owners in achieving wealth through commercial real estate ownership. The company specializes in offering commercial real estate loans, including Small Business Administration (SBA) 504 loans and low loan-to-value conventional loans. By streamlining the lending process, Fountainhead enables business owners to make quick credit decisions and facilitate fast closings, addressing the common financial barriers that prevent them from purchasing commercial property. This approach allows business owners to invest in real estate, which is recognized as a valuable long-term asset, enhancing their overall net worth.

MPLX

Post in 2016
MPLX is a pipeline company formed by Marathon Petroleum Corporation that operates a broad network of crude oil and product pipelines and related storage assets across the Midwest and Gulf Coast of the United States. It owns, leases, or has ownership interests in about 2,900 miles of pipeline across nine states, delivering crude and refined products through a common carrier system. The pipeline network forms a major U.S. logistics backbone, ranking among the largest by total annual volumes delivered.

SurgRx

Series F in 2007
SurgRx is a developer of laparoscopic vessel fusion tools for surgical hemostasis.

Kintera

Post in 2006
Kintera is leader and pioneering provider of Software as a Service (SaaS) solutions to the nonprofit and government sectors. They are a leading provider of software that enables nonprofit organizations to use the Internet to bring their employees, volunteers and donors together in online, interactive communities that increase donations, reduce fundraising costs and build affinity for an organization's cause.

PosiGen

PosiGen provides residential renewable energy and energy efficiency solutions. As a Third Party Ownership company, it offers solar systems and energy-efficient retrofits to low- to moderate-income homeowners, helping them reduce utility bills and achieve greater financial autonomy.

TensorWave

TensorWave specializes in providing advanced AI and high-performance computing (HPC) cloud infrastructure. It offers scalable, memory-optimized technology powered by AMD Instinct GPUs, ensuring high performance and energy efficiency for demanding AI and machine learning workloads. The company's services include direct liquid cooling, high-speed network storage, and seamless integration capabilities, enabling enterprises to effectively harness the power of artificial intelligence.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.